Rapid Rise of Antibiotic-Resistant Gonorrhea Strains in China: From 2.9% in 2017 to 8.1% in 2021
Rapid increase from 2.9% in 2017 to 8.1% in 2021 Posted on 03.29.2024 at 8.00pm Posted on 03.29.2024 at 8.00pm Modified on 03.29.2024 at 1.36pm Views 0 Strains resistant to ceftriaxone, the first-line antibiotic for the treatment of gonorrhea, first appeared in China in 2016 and accounted for 2.9% of gonococcal infections in 2017, but […]
The Urgency of Addressing Antimicrobial Resistance: 5 Reasons Europe and Korea Should Take Action
Title: The Threat of Antimicrobial Resistance: A Growing Concern in Europe The Alarming Reality of Antibiotic Resistance In Europe, antibiotic-resistant bacteria claim the lives of 100 individuals each day, while approximately 800,000 people annually suffer from infections caused by these resilient strains. Worryingly, Korea is also grappling with this global health crisis, prompting the European […]
Voronoi Seeks Phase 1 Approval for Non-Small Cell Lung Cancer Treatment
Voronoi Applies for Phase 1 Clinical Trial Approval for NSCLC Treatment The innovative drug design company Voronoi, led by CEO Kim Dae-kwon and Kim Hyeon-tae, has submitted an application for approval of the phase 1 clinical trial design (IND) for VRN11, a potential treatment for non-small cell lung cancer (NSCLC), to the Food and Drug […]
Intronbio, new VRE drug ‘EFL2200’ confirms broad spectrum antibacterial efficacy
Today’s Money Reporter Kim Do-yoon | 2023.06.19 11:08 Intron Bio announced on the 19th that it has confirmed the broad-spectrum antibacterial efficacy of ‘EFL2200’, a new bio-drug targeting VRE (Vancomycin-resistant Enterococci). VRE is one of the resistant bacteria that poses a serious threat to human health, warned by the US Centers for Disease Control and […]
Lemonex “siRNA gene therapy, safety and tolerability confirmed in phase 1 clinical trial in Korea”
Lemonex (CEO Won Cheol-hee), a company specializing in next-generation drug delivery platforms, announced on the 12th that it has received a Clinical Study Report (CSR) of a phase 1 clinical trial for hypertrophic scar treatment. Lemonex previously received approval from the Food and Drug Safety Administration for a phase 1 clinical trial design (IND) for […]
